SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-058131
Filing Date
2021-11-10
Accepted
2021-11-10 16:16:00
Documents
52
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0921_hoththera.htm   iXBRL 10-Q 563564
2 CERTIFICATION f10q0921ex31-1_hoththerap.htm EX-31.1 10050
3 CERTIFICATION f10q0921ex31-2_hoththerap.htm EX-31.2 10098
4 CERTIFICATION f10q0921ex32-1_hoththerap.htm EX-32.1 3454
5 CERTIFICATION f10q0921ex32-2_hoththerap.htm EX-32.2 3593
  Complete submission text file 0001213900-21-058131.txt   3260319

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hoth-20210930.xsd EX-101.SCH 45879
7 XBRL CALCULATION FILE hoth-20210930_cal.xml EX-101.CAL 24923
8 XBRL DEFINITION FILE hoth-20210930_def.xml EX-101.DEF 175570
9 XBRL LABEL FILE hoth-20210930_lab.xml EX-101.LAB 351575
10 XBRL PRESENTATION FILE hoth-20210930_pre.xml EX-101.PRE 189610
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921_hoththera_htm.xml XML 360249
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38803 | Film No.: 211396823
SIC: 2834 Pharmaceutical Preparations